You are here


Posted on Thursday, February 4, 2021 - 1:02pm
Haematologica. 2020 Dec 1; 105(12): 2738–2745.Published online 2020 Oct 9. doi: 10.3324/haematol.2019.242891
Posted on Tuesday, January 26, 2021 - 3:35pm
Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic...
Posted on Saturday, October 10, 2020 - 3:01pm
While the world eagerly awaits an effective vaccine, the current focus is on drug treatments.
Posted on Monday, August 31, 2020 - 5:49pm
In order to harmonize and standardize the management of patients with chronic myeloid leukemia (CML), the European LeukemiaNet (ELN) produced recommendations in the previous years.
Posted on Monday, August 31, 2020 - 5:39pm
Authors: Graeme Smith  Jane Apperley  Dragana Milojkovic  Nicholas C. P.
Posted on Thursday, August 27, 2020 - 11:23am
Press Release
Posted on Monday, June 22, 2020 - 9:48am
A really interesting paper on the management and incidence of COVID-19 in CML patients in Italy  
Posted on Thursday, June 4, 2020 - 2:17pm
We studied by questionnaire 530 subjects with chronic myeloid leukaemia (CML) in Hubei Province during the recent SARS-CoV-2 epidemic.
Posted on Saturday, April 11, 2020 - 1:35am
As the UK and the world see many more people test positive for COVID-19 You can help collect important data with this free symptom tracker by monitoring your day to day health and wellbeing.      &
Posted on Friday, April 3, 2020 - 2:59pm
It is important to note that the questions and answers below refer to chronic phase CML. Management of accelerated phase, blast crisis or post-transplant should be discussed in detail with the clinical team.
Posted on Monday, March 23, 2020 - 3:49pm
Expert Opinion from the NCRI CML Subgroup 17th Mar 2020, updated 27th March 2020 The latest UK government updates are listed here:
Posted on Sunday, March 22, 2020 - 5:04pm
This guidance is for people, including children, who are at very high risk of severe illness from coronavirus (COVID-19) because of an underlying health condition, and for their family, friends and carers.